InsiderDirector
Howard G. Welgus Insider Trading Activity
Every SEC Form 4 transaction reported by Howard G. Welgus, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is Howard G. Welgus buying or selling?
Howard G. Welgus reported 0 open-market buys ($0) and 55 sells ($6.5M) across 55 Form 4 filings at 1 company — a net selling position of $6.5M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 17, 2026)
Total Form 4 filings
55
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (55)
$6.5M
Insider sentiment
Net sellingNet insider flow of $6.5M in net selling, filed between Aug 5, 2020 – Jul 17, 2026.
Companies Howard G. Welgus files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | ARQTArcutis Biotherapeutics, Inc. | 55 |
Recent Howard G. Welgus transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Jul 17, 2026 | ARQT | Director | Sale | 4.7K | $127.3K |
| Jun 18, 2026 | ARQT | Director | Sale | 4.7K | $116.3K |
| May 6, 2026 | ARQT | Director | Sale | 7.1K | $164.2K |
| Apr 3, 2026 | ARQT | Director | Sale | 10.0K | $238.8K |
| Mar 4, 2026 | ARQT | Director | Sale | 10.0K | $256.5K |
| Feb 5, 2026 | ARQT | Director | Sale | 10.0K | $250.5K |
| Jan 6, 2026 | ARQT | Director | Sale | 10.0K | $289.6K |
| Dec 3, 2025 | ARQT | Director | Sale | 10.0K | $302.1K |
| Nov 5, 2025 | ARQT | Director | Sale | 10.0K | $252.7K |
| Oct 3, 2025 | ARQT | Director | Sale | 10.0K | $189.2K |
| Sep 4, 2025 | ARQT | Director | Sale | 10.0K | $156.4K |
| Aug 5, 2025 | ARQT | Director | Sale | 10.0K | $143.0K |
| Jul 2, 2025 | ARQT | Director | Sale | 9.2K | $127.4K |
| Jun 20, 2025 | ARQT | Director | Sale | 10.1K | $135.6K |
| May 5, 2025 | ARQT | Director | Sale | 10.0K | $146.4K |
| Apr 3, 2025 | ARQT | Director | Sale | 10.0K | $151.2K |
| Mar 5, 2025 | ARQT | Director | Sale | 10.0K | $130.0K |
| Feb 5, 2025 | ARQT | Director | Sale | 10.0K | $127.1K |
| Jan 6, 2025 | ARQT | Director | Sale | 10.0K | $146.7K |
| Dec 3, 2024 | ARQT | Director | Sale | 10.0K | $125.1K |
| Nov 5, 2024 | ARQT | Director | Sale | 10.0K | $86.5K |
| Oct 3, 2024 | ARQT | Director | Sale | 10.0K | $92.6K |
| Sep 5, 2024 | ARQT | Director | Sale | 10.0K | $107.7K |
| Aug 5, 2024 | ARQT | Director | Sale | 10.0K | $98.7K |
| Jul 2, 2024 | ARQT | Director | Sale | 10.0K | $93.1K |
Showing the 25 most recent filings of 55. Screen every filing.
Howard G. Welgus insider trading FAQ
Is Howard G. Welgus buying or selling?
Across 55 SEC Form 4 filings, Howard G. Welgus reported 0 open-market purchases totaling $0 and 55 sales totaling $6.5M — a net selling position of $6.5M.
Which companies does Howard G. Welgus file Form 4s for?
Howard G. Welgus has reported insider transactions at 1 company, most often Arcutis Biotherapeutics, Inc. (ARQT).
How far back does Howard G. Welgus's filing history go?
Trabud holds Howard G. Welgus's SEC Form 4 filings from Aug 5, 2020 – Jul 17, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Howard G. Welgus's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Howard G. Welgus and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener